ResMed RMD Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's additional paid-in capital?
- ResMed (RMD) reported additional paid-in capital of $2.13B in Q1 2026.
- How has ResMed's additional paid-in capital changed year-over-year?
- ResMed's additional paid-in capital increased by 7.2% year-over-year, from $1.99B to $2.13B.
- What is the long-term trend for ResMed's additional paid-in capital?
- Over 4 years (2021 to 2025), ResMed's additional paid-in capital has grown at a 5.8% compound annual growth rate (CAGR), from $1.62B to $2.03B.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.